cerrar

Cyprus

New Special Report on Pharma in Cyprus

With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with the island now on the road to economic recovery following…

Cyprus: Sun, Sea and…Surgery?

Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important…

Cyprus Joins the Cannabis Craze

In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the…

Mario Sciberras – General Manager Cyprus, Malta and Gibraltar, GSK

Mario Sciberras, former general manager for Malta and Gibraltar became general manager for Cyprus, Malta, and Gibraltar in 2016. In this interview, he touches on themes of transparency, GSK’s positioning…

In Conversation

Nicos Anastasiades – President, Republic of Cyprus

In an exclusive interview, President Nicos Anastasiades outlines his public health priorities, the continuing importance of the pharmaceutical industry to Cyprus’s economy, and the nation’s attractiveness as an international investment destination. Ensuring our citizens’ good health is not negotiable. What are your main priorities and policies for public health for your second term? Apart from the major reform of the…

George Campanellas – Director General, Invest Cyprus…

Iacovos Ghalanos – Life Sciences Head, KPMG Cyprus

George Campanellas – Director General, Invest Cyprus (Cyprus Investment…

George Campanellas provides an overview of Invest Cyprus’ strategy for attracting foreign investment into Cyprus. He touches on sourcing interest from a wide range of sectors and highlights what makes…

Varnavas Varnava – Founder and Director, Biotronics, Cyprus

Varnavas Varnava, the founder and director of Biotronics, highlights the importance of diversification when operating in a small market, as well as discloses his future plans for the company and…

Philippos Patsalis – CEO and Founder, NIPD Genetics, Cyprus

Philippos Patsalis, CEO and founder of NIPD Genetics, tells the story of the creation of Cyprus’s first ever biotech company and all its accomplishments after seven years of existence. He…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here